Breaking News Instant updates and real-time market news.

BOLD

Audentes Therapeutics

$18.43

0.32 (1.77%)

, AVXS

AveXis

$47.51

2.35 (5.20%)

10:09
10/10/16
10/10
10:09
10/10/16
10:09

AveXis data bodes well for Audentes gene therapy program, says Piper Jaffray

Piper Jaffray analyst Joshua Schimmer said additional data presented by AveXis (AVXS) from its ongoing Phase 1/2 trial in infantile-onset spinal muscular atrophy "augurs well" for Audentes Therapeutics' (BOLD) gene therapy program for X-linked myotubular myopathy, as he sees several points of similarity that provide a positive read-through though the companies are targeting different diseases. Schimmer, who does not have a rating on AveXis, reiterates his Overweight rating and $24 price target on Audentes shares.

BOLD

Audentes Therapeutics

$18.43

0.32 (1.77%)

AVXS

AveXis

$47.51

2.35 (5.20%)

  • 10

    Oct

  • 06

    Nov

BOLD Audentes Therapeutics
$18.43

0.32 (1.77%)

08/15/16
PIPR
08/15/16
INITIATION
Target $24
PIPR
Overweight
Audentes Therapeutics initiated with an Overweight at Piper Jaffray
Piper Jaffray analyst Joshua Schimmer started Audentes Therapeutics with an Overweight rating and $24 price target. The analyst views the company as well-positioned in the "rapidly evolving gene therapy landscape."
08/15/16
COWN
08/15/16
INITIATION
COWN
Outperform
Audentes Therapeutics initiated with an Outperform at Cowen
Cowen analyst Ritu Baral started Audentes Therapeutics with an Outperform rating.
08/15/16
WEDB
08/15/16
INITIATION
Target $20
WEDB
Outperform
Audentes Therapeutics initiated with an Outperform at Wedbush
Wedbush analyst David Nierengarten initiated Audentes Therapeutics with an Outperform and $20 price target saying its a compelling opportunity in AAV gene therapy of rare diseases.
AVXS AveXis
$47.51

2.35 (5.20%)

09/26/16
PIPR
09/26/16
NO CHANGE
Target $46
PIPR
Overweight
Ionis nusinersen program advancing faster than expected, says Piper Jaffray
After Biogen (BIIB) and Ionis (IONS) announced that Biogen has completed the rolling submission of a New Drug Application to the U.S. FDA for the approval of nusinersen, an investigational treatment for spinal muscular atrophy, Piper Jaffray analyst Joshua Schimmer said that the nusinersen program is advancing faster than many have expected. Nusinersen may launch before AveXis (AVXS) starts its next Phase 3 trial, added Schimmer, who believes nusinersen will emerge as a multi-billion dollar product. The analyst keeps an Overweight rating and $46 price target on Ionis shares.
09/28/16
JEFF
09/28/16
NO CHANGE
Target $50
JEFF
Buy
Jefferies parent survey shows interest in AveXis pivotal trial
Jefferies analyst Biren Amin conducted a survey of parents of spinal muscular atrophy patients amid investor questions surrounding AveXis' (AVXS) ability to enroll a pivotal trial with AVXS-101 given the open access program with nusinersen, the investigational drug being developed by Ionis Pharmaceuticals (IONS) and Biogen (BIIB). Parents value the option of nusinersen treatment but are also willing to enroll in clinical trials of AVXS-101, Amin tells investors in a research note, citing his survey of seven parents. A single arm trial of AVXS-101 was the most preferred clinical trial design for the upcoming Phase 3 of AVXS-101, he added. The analyst believes his parent responses suggest excitement over nusinersen but also a willingness to enroll into the AVXS-101 trials, especially if it is a single-arm trial. Parents were also attracted to AVXS-101 intravenous delivery, which could be a "meaningful advantage," Amin contends. The analyst keeps a Buy rating on AveXis with a $50 price target. The stock closed yesterday up 88c to $41.00. Amin caused a rally in AveXis shares on September 19 when writing about finding a video online of a spinal muscular atrophy baby walking that he believed to be a patient in the company's trial of AVXS-101.
10/06/16
GSCO
10/06/16
NO CHANGE
Target $71
GSCO
Buy
AveXis attractive acquisition target, price target to $71 at Goldman
Goldman analyst Salveen Richter said AveXis has two approaching catalysts coming up, the AVXS-101 update in SMA Type 1 at the World Muscle Society, or WMS, on October 8, and clarity on the AVXS-101 pivotal trial design in late October/early November. The analyst expects positive WMS data and raaised his probability of success to 60% from 45%. He expects compelling motor milestone data and pivotal trial visibility to make AveXis an attractive acquisition target and raised his price target to $71 from $46 on shares and reiterated his Buy rating.
10/07/16
GSCO
10/07/16
NO CHANGE
GSCO
Smid-cap Biotech sector upgraded to Attractive from Neutral at Goldman
Goldman analyst Salveen Richter upgraded the Smid-cap biotechnology to Attractive and said he favors and companies with near-term pipeline data or regulatory events where he has conviction.Names he recommends are Buy rated BioMarin (BMRN), bluebird bio (BLUE), GW Pharma (GWPH), Incyte (INCY), Kite (KITE), and Sage (SAGE).

TODAY'S FREE FLY STORIES

CBI

CB&I

$20.79

0.7683 (3.84%)

13:40
06/28/17
06/28
13:40
06/28/17
13:40
Options
Call buyer opens a big new position in Chicago Bridge and Iron »

Call buyer opens a big…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:40
06/28/17
06/28
13:40
06/28/17
13:40
General news
FX Action: USD-JPY »

FX Action: USD-JPY has…

EGO

Eldorado Gold

$2.72

-0.1 (-3.55%)

13:37
06/28/17
06/28
13:37
06/28/17
13:37
Downgrade
Eldorado Gold rating change  »

Eldorado Gold downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jul

GOOS

Canada Goose

$20.60

-0.49 (-2.32%)

13:30
06/28/17
06/28
13:30
06/28/17
13:30
Upgrade
Canada Goose rating change  »

Canada Goose upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

13:25
06/28/17
06/28
13:25
06/28/17
13:25
Conference/Events
JPMorgan life sciences analyst holds an analyst/industry conference call »

Life Science Tools &…

MU

Micron

$31.66

-0.84 (-2.58%)

13:24
06/28/17
06/28
13:24
06/28/17
13:24
Hot Stocks
Nanya Technology lowers Micron stake to 4.17% with recent sale of 11.6M shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

  • 29

    Aug

BPY

Brookfield Property

$24.08

0.34 (1.43%)

13:22
06/28/17
06/28
13:22
06/28/17
13:22
Conference/Events
Brookfield Property management to meet with RBC Capital »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

13:20
06/28/17
06/28
13:20
06/28/17
13:20
General news
Treasury's $28 B 7-year auction results fell to the soft side »

Treasury's $28 B…

BPOP

Popular

$39.33

0.16 (0.41%)

13:19
06/28/17
06/28
13:19
06/28/17
13:19
Conference/Events
Popular management to meet with RBC Capital »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 26

    Sep

  • 27

    Sep

$NSD

NASDAQ Market Internals

13:17
06/28/17
06/28
13:17
06/28/17
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MEOH

Methanex

$42.30

0.4 (0.95%)

13:16
06/28/17
06/28
13:16
06/28/17
13:16
Conference/Events
Methanex management to meet with RBC Capital »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

$NYE

NYSE Market Internals

13:16
06/28/17
06/28
13:16
06/28/17
13:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:15
06/28/17
06/28
13:15
06/28/17
13:15
General news
Treasury Action: intermediate yields ticked higher »

Treasury Action:…

CS

Credit Suisse

$14.45

0.2 (1.40%)

13:14
06/28/17
06/28
13:14
06/28/17
13:14
Syndicate
Breaking Syndicate news story on Credit Suisse »

Credit Suisse files $85B…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IMGN

ImmunoGen

$6.54

-0.28 (-4.11%)

13:12
06/28/17
06/28
13:12
06/28/17
13:12
Conference/Events
ImmunoGen management to meet with RBC Capital »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 28

    Jun

VZ

Verizon

$44.85

0.005 (0.01%)

, GOOG

Alphabet

$927.33

-24.94 (-2.62%)

13:09
06/28/17
06/28
13:09
06/28/17
13:09
Periodicals
Verizon explores pooling consumer data with other wireless firms, BI says »

After closing its…

VZ

Verizon

$44.85

0.005 (0.01%)

GOOG

Alphabet

$927.33

-24.94 (-2.62%)

GOOGL

Alphabet Class A

$948.09

-24 (-2.47%)

FB

Facebook

$150.58

-3.01 (-1.96%)

TMUS

T-Mobile

$61.01

-2.14 (-3.39%)

S

Sprint

$8.14

-0.04 (-0.49%)

VOD

Vodafone

$28.65

-0.145 (-0.50%)

TEF

Telefonica

$10.53

-0.1 (-0.94%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 28

    Jun

  • 19

    Jul

  • 27

    Jul

  • 03

    Aug

MIC

Macquarie Infrastructure

$79.18

0.8299 (1.06%)

13:09
06/28/17
06/28
13:09
06/28/17
13:09
Conference/Events
Macquarie Infrastructure management to meet with RBC Capital »

Meeting to be held in the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 18

    Jul

  • 19

    Jul

13:05
06/28/17
06/28
13:05
06/28/17
13:05
General news
7-Yr Note Auction Coupon Rate data reported »

7-Yr Note Auction Coupon…

13:05
06/28/17
06/28
13:05
06/28/17
13:05
General news
7-Yr Note Auction Total Amount data reported »

7-Yr Note Auction Total…

13:05
06/28/17
06/28
13:05
06/28/17
13:05
General news
Treasury Option Action: bullish 10-year positioning »

Treasury Option Action:…

MTCH

Match Group

$17.50

-0.295 (-1.66%)

13:04
06/28/17
06/28
13:04
06/28/17
13:04
Hot Stocks
Tinder introduces Tinder Gold premium service »

Match Group's Tinder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RAD

Rite Aid

$4.04

0.2989 (7.99%)

, WBA

Walgreens Boots Alliance

$77.26

-0.27 (-0.35%)

13:02
06/28/17
06/28
13:02
06/28/17
13:02
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

RAD

Rite Aid

$4.04

0.2989 (7.99%)

WBA

Walgreens Boots Alliance

$77.26

-0.27 (-0.35%)

MKC

McCormick

$98.40

-0.135 (-0.14%)

LNN

Lindsay

$87.92

1.32 (1.52%)

GBX

Greenbrier

$50.15

0.7 (1.42%)

CAG

Conagra Brands

$37.53

0.525 (1.42%)

STZ

Constellation Brands

$183.93

1.65 (0.91%)

AYI

Acuity Brands

$180.03

4.695 (2.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

  • 29

    Jun

  • 29

    Jun

  • 29

    Jun

  • 29

    Jun

  • 29

    Jun

  • 29

    Jun

  • 07

    Jul

GOOG

Alphabet

$927.33

-24.94 (-2.62%)

, GOOGL

Alphabet Class A

$948.09

-24 (-2.47%)

13:02
06/28/17
06/28
13:02
06/28/17
13:02
Periodicals
Alphabet sought to sell Nest last year, Reuters reports »

At a certain point in…

GOOG

Alphabet

$927.33

-24.94 (-2.62%)

GOOGL

Alphabet Class A

$948.09

-24 (-2.47%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 28

    Jun

  • 19

    Jul

PIR

Pier 1 Imports

$5.42

0.0799 (1.50%)

, SHLM

A. Schulman

$27.50

-1.05 (-3.68%)

13:02
06/28/17
06/28
13:02
06/28/17
13:02
Earnings
Notable companies reporting after market close »

Notable companies…

PIR

Pier 1 Imports

$5.42

0.0799 (1.50%)

SHLM

A. Schulman

$27.50

-1.05 (-3.68%)

PRGS

Progress Software

$30.08

-0.16 (-0.53%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 28

    Jun

  • 29

    Jun

AMZN

Amazon.com

$976.78

-17.2 (-1.73%)

, GOOG

Alphabet

$927.33

-24.94 (-2.62%)

13:00
06/28/17
06/28
13:00
06/28/17
13:00
Hot Stocks
Best Buy to launch Amazon Alexa, Google Home 'experiences' in 700 stores »

Best Buy (BBY) announced…

AMZN

Amazon.com

$976.78

-17.2 (-1.73%)

GOOG

Alphabet

$927.33

-24.94 (-2.62%)

GOOGL

Alphabet Class A

$948.09

-24 (-2.47%)

BBY

Best Buy

$56.96

0.78 (1.39%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 28

    Jun

  • 19

    Jul

  • 29

    Aug

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.